Heptarise Syrup is a pharmaceutical formulation containing Cyproheptadine hydrochloride (2 mg per 5 ml) and Tricholine Citrate (275 mg per 5 ml), designed to provide antihistaminic and hepatoprotective effects. Cyproheptadine is a potent first-generation antihistamine with antiserotonergic properties, commonly employed in the management of allergic conditions such as rhinitis, urticaria, and other hypersensitivity reactions by antagonizing H1 histamine receptors, thereby reducing symptoms like itching, sneezing, and nasal congestion. Tricholine Citrate serves as a choleretic and hepatoprotective agent, facilitating bile secretion and promoting liver function, which is beneficial in conditions involving hepatic insufficiency or cholestasis. The combination in Heptarise Syrup offers a dual therapeutic approach, addressing allergic manifestations while supporting liver health. It is indicated for patients requiring symptomatic relief from allergic disorders alongside improvement of hepatic function. The syrup formulation ensures ease of administration, particularly in pediatric and geriatric populations. Dosage and duration of treatment should be determined by a healthcare professional based on the severity of symptoms and patient response. Caution is advised in patients with known hypersensitivity to either component, and the product should be used under medical supervision to monitor for potential adverse effects such as sedation or gastrointestinal disturbances.